Medicine News and Research

RSS

Antiparasitic drug Ivermectin kills coronavirus in 48 hours

Around the world, scientists race to develop a vaccine or treatment against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Now, a team of researchers has found that a drug already available around the world can kill the coronavirus in a lab setting in just 48 hours.

6 Apr 2020

Autoimmunity-associated heart dilation linked with heart-failure risk in type 1 diabetes

People with type 1 diabetes, particularly those with poor glycemic control, are at markedly increased risk for cardiovascular disease than the general population.

6 Apr 2020

McMaster: Common medical masks are good for most COVID-19 treatment

The N95 respirator masks should be preserved for health-care workers involved in inserting breathing tubes for patients with COVID-19. More common medical masks are fine for all other COVID-19 treatment, says preliminary research from McMaster University.

6 Apr 2020

Texas A&M chemists focus on searching for drugs to treat COVID-19

In the wake of the novel coronavirus pandemic, Texas A&M University chemist Wenshe Ray Liu and his research team have focused their lab solely on searching for drugs to treat COVID-19.

6 Apr 2020

New website provides updated information on antiviral options for COVID-19

The website, created by medical professionals from the Norwegian University of Science and Technology (NTNU) and St Olavs Hospital can be found at https://sars-coronavirus-2.info/.

6 Apr 2020

Mount Sinai launches web-based app to capture symptoms, spread of COVID-19 in New York City

A team of data scientists, physicians, and engineers across the Mount Sinai Health System has come together to launch STOP COVID NYC, a web-based app to capture the symptoms and spread of COVID-19 in New York City--currently the epicenter of the nation's largest outbreak.

6 Apr 2020

New antiviral drug could change the way doctors treat COVID-19

Scientists are hopeful that a new drug -- called EIDD-2801 -- could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials.

6 Apr 2020

Scientist proposes geroprotective strategies to reduce lethality of COVID-19 in the elderly

The Biogerontology Research Foundation, a registered UK charity supporting and promoting aging and longevity research worldwide since 2008, today announced the publication of a paper titled "Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections" in the leading journal Aging.

6 Apr 2020

Penn-led trial to evaluate the effectiveness of HCQ in combating COVID-19 pandemic

A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.

6 Apr 2020

Experimental drug APN01 prevents COVID-19 infection in the lab

With the world gripped with the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is a frantic rush to find an effective drug that can be used to treat the disease.

6 Apr 2020

Healthy lifestyle, greater disease-free life expectancy

For years, doctors have been advocating a healthy diet, more regular exercise, stress relief, and weight control. However, no study has examined a combination of all these factors with the number of years that one can live free of major chronic disease. This could help communicate the benefits of a healthy lifestyle more convincingly than the commonly reported relative risk of disease with each of these risk factors.

6 Apr 2020

Alzheimer's disease: high amyloid levels linked to early disease

A new study published in the journal JAMA Neurology in April 2020 seems to indicate that higher brain amyloid levels represent early Alzheimer's disease (AD).

6 Apr 2020

ATS releases new guidance to help clinicians manage COVID-19 patients

An American Thoracic Society-led international task force has released a guidance document to help clinicians manage COVID-19 patients in the face of a worldwide pandemic and minimal empirical evidence to guide treatment.

6 Apr 2020

DsbA-L gene may play a role in protecting respiratory function of the elderly

The lungs are constantly exposed to the external environment and maintain homeostasis by adapting to stress and tissue damage.

6 Apr 2020

Analysis of causative protein genotype can help predict Alport syndrome severity

A Japanese research team has successfully developed a system to predict the severity of Alport syndrome, a serious hereditary kidney disease that occurs in about 1 out of 5,000 people in the US. Patients with Alport syndrome have abnormalities in the causative protein, type IV collagen, that often lead to chronic renal dysfunction requiring dialysis.

6 Apr 2020

UC San Diego Health expands COVID-19 testing capacity

From the beginning, the ability of front line clinicians to test patients for COVID-19 -- to determine whether a person is infected with the disease-causing novel coronavirus, SARS-CoV-2 -- has been part and parcel of the pandemic.

6 Apr 2020

STEMCELL launches 'My Status' app to help keep staff safe during COVID-19 pandemic

OutSystems announced that STEMCELL Technologies has launched its "My Status" app to help keep STEMCELL staff safe during the COVID-19 pandemic.

6 Apr 2020

GlobalData: Digital biomarkers emerging as key predictive tools to manage COVID-19 pandemic

Remote patient monitoring is accelerating the development and validation of digital biomarkers to help identify patients that are at risk from the coronavirus (COVID-19), supporting the assessment of disease progression and allowing continuous monitoring of disease symptoms, as well as providing data for new outbreaks, says GlobalData, a leading data and analytics company.

6 Apr 2020

Study suggests targeted cancer therapy could help with rare neurologic disease

A targeted therapy currently studied for treatment of certain cancers may be beneficial in treating other neurologic diseases.

6 Apr 2020

Researchers uncover genetic mutation responsible for aggressive head and neck, lung cancers

Researchers from the Cancer Science Institute of Singapore at the National University of Singapore have uncovered a genetic variant in a gene called MET that is responsible for more aggressive growth of head and neck, and lung cancers.

6 Apr 2020

Medicine News and Research

Antiparasitic drug Ivermectin kills coronavirus in 48 hours

Autoimmunity-associated heart dilation linked with heart-failure risk in type 1 diabetes

McMaster: Common medical masks are good for most COVID-19 treatment

Texas A&M chemists focus on searching for drugs to treat COVID-19

New website provides updated information on antiviral options for COVID-19

Mount Sinai launches web-based app to capture symptoms, spread of COVID-19 in New York City

New antiviral drug could change the way doctors treat COVID-19

Scientist proposes geroprotective strategies to reduce lethality of COVID-19 in the elderly

Penn-led trial to evaluate the effectiveness of HCQ in combating COVID-19 pandemic

Experimental drug APN01 prevents COVID-19 infection in the lab

Healthy lifestyle, greater disease-free life expectancy

Alzheimer's disease: high amyloid levels linked to early disease

ATS releases new guidance to help clinicians manage COVID-19 patients

DsbA-L gene may play a role in protecting respiratory function of the elderly

Analysis of causative protein genotype can help predict Alport syndrome severity

UC San Diego Health expands COVID-19 testing capacity

STEMCELL launches 'My Status' app to help keep staff safe during COVID-19 pandemic

GlobalData: Digital biomarkers emerging as key predictive tools to manage COVID-19 pandemic

Study suggests targeted cancer therapy could help with rare neurologic disease

Researchers uncover genetic mutation responsible for aggressive head and neck, lung cancers

Everything there is to know about biosimilars eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News